Pathophysiologic and pharmacologic approaches in heart failure with preserved ejection fraction induced experimentally by pressure-overload and obesity

被引:0
|
作者
Pop, C. [1 ]
Stoicescu, L. [2 ]
Muntean, D. M. [3 ]
Stefan, M. G. [4 ]
Gal, A. F. [5 ]
Lauzier, B. [6 ]
Morgovan, C. [7 ]
Kiss, B. [4 ]
Loghin, F. [4 ]
Mogosan, C. [1 ]
Ghibu, S. M. [1 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Physiol & Pathophysiol, Fac Pharm, Cluj Napoca, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Dept Cardiol, Med Clin 5, Cluj Napoca, Romania
[3] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmaceut Technol & Biopharm, Fac Pharm, Cluj Napoca, Romania
[4] Iuliu Hatieganu Univ Med & Pharm, Dept Toxicol, Fac Pharm, Cluj Napoca, Romania
[5] Univ Agr Sci & Vet Med, Dept Cell Biol Histol & Embryol, Fac Vet Med, Cluj Napoca, Romania
[6] Inst Thorax, Nantes, France
[7] Lucian Blaga Univ, Preclin Dept, Fac Med, Sibiu, Romania
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1471
引用
收藏
页码:270 / 271
页数:2
相关论文
共 50 条
  • [21] A Porcine Model of Heart Failure With Preserved Ejection Fraction Induced by Chronic Pressure Overload Characterized by Cardiac Fibrosis and Remodeling
    Tan, Weijiang
    Li, Xiang
    Zheng, Shuang
    Li, Xiaohui
    Zhang, Xiaoshen
    Pyle, W. Glen
    Chen, Honghua
    Wu, Jian
    Sun, Huan
    Zou, Yunzeng
    Backx, Peter H.
    Yang, Feng Hua
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [22] Pressure-volume Profiles In Heart Failure With Reduced Ejection Fraction And Heart Failure With Preserved Ejection Fraction
    Kittipibul, Veraprapas
    Yaranov, Dmitry
    Rao, Vishal
    Jefferies, John
    Silver, Marc A.
    Fudim, Marat
    JOURNAL OF CARDIAC FAILURE, 2023, 29 (04) : 603 - 603
  • [23] Current Status of Pharmacologic and Nonpharmacologic Therapy in Heart Failure with Preserved Ejection Fraction
    Kim, Mi-Na
    Park, Seong-Mi
    HEART FAILURE CLINICS, 2021, 17 (03) : 463 - 482
  • [24] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Taher M. Mandviwala
    Sukhdeep S. Basra
    Umair Khalid
    June K. Pickett
    Ryle Przybylowicz
    Tina Shah
    Vijay Nambi
    Salim S. Virani
    Anita Deswal
    International Journal of Obesity, 2020, 44 : 1561 - 1567
  • [25] Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults
    Hashemi, Ashkan
    Kwak, Min Ji
    Goyal, Parag
    DRUGS & AGING, 2025, 42 (02) : 95 - 110
  • [26] Obesity and the paradox of mortality and heart failure hospitalization in heart failure with preserved ejection fraction
    Mandviwala, Taher M.
    Basra, Sukhdeep S.
    Khalid, Umair
    Pickett, June K.
    Przybylowicz, Ryle
    Shah, Tina
    Nambi, Vijay
    Virani, Salim S.
    Deswal, Anita
    INTERNATIONAL JOURNAL OF OBESITY, 2020, 44 (07) : 1561 - 1567
  • [27] Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction
    Sorimachi, Hidemi
    Obokata, Masaru
    Takahashi, Naoki
    Reddy, Yogesh N., V
    Jain, Christopher C.
    Verbrugge, Frederik H.
    Koepp, Katlyn E.
    Khosla, Sundeep
    Jensen, Michael D.
    Borlaug, Barry A.
    EUROPEAN HEART JOURNAL, 2021, 42 (16) : 1595 - 1605
  • [28] Heart failure with preserved ejection fraction
    Kessler, Kenneth M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1829 - 1829
  • [29] Heart Failure with Preserved Ejection Fraction
    Meyer, Adam
    Kerrigan, Martin
    HOSPITAL MEDICINE CLINICS, 2015, 4 (03) : 283 - 296
  • [30] Heart Failure with Preserved Ejection Fraction
    Gladden, James D.
    Chaanine, Antoine H.
    Redfield, Margaret M.
    ANNUAL REVIEW OF MEDICINE, VOL 69, 2018, 69 : 65 - 79